Lifecome Biochemistry Co.,Ltd.

SZSE:002868.SZ

24.39 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 166.032159.238109.332167.631129.851100.19195.78289.80281.57962.687111.23678.30682.91490.9367.16762.92795.54682.50583.27476.86175.78967.83590.64485.60278.71389.33386.87102.27789.12197.14494.64583.237108.468115.14
Cost of Revenue 179.352147.307153.346192.288119.37687.421106.164100.30777.57955.054108.40263.10864.64367.64664.73941.454.3954.09150.3252.8452.43247.14162.35654.54649.76858.71159.6757.67751.155.13267.98551.00758.43766.56
Gross Profit -13.31911.931-44.015-24.65710.47512.77-10.382-10.50547.6332.83415.19818.27123.2852.42721.52741.15728.41432.95424.02123.35720.69428.28831.05628.94530.62227.19944.638.02142.01226.6632.2350.03248.58
Gross Profit Ratio -0.080.075-0.403-0.1470.0810.127-0.108-0.1170.0490.1220.0250.1940.220.2560.0360.3420.4310.3440.3960.3130.3080.3050.3120.3630.3680.3430.3130.4360.4270.4320.2820.3870.4610.422
Reseach & Development Expenses 11.3137.8357.916.4927.5185.613.4126.0786.555.7854.9327.3096.2996.283.2026.556.413.7523.8216.5793.9324.2184.3034.1882.3363.7393.4233.746.944013.17107.5490
General & Administrative Expenses -6.71312.219-7.60614.633-2.817.027-12.79315.078-0.644.301-8.91511.244-1.6444.299-7.0014.25-1.5723.728-6.6853.107-1.2582.986-6.182.694-3.7915.94-16.6747.849-3.2435.725-16.0464.6768.7976.006
Selling & Marketing Expenses 4.4333.6785.0663.933.5313.3993.642.4342.2372.5053.7733.8244.0013.372-3.3274.2025.485.5316.7445.0075.6093.8266.4334.5755.4734.3485.1395.9354.934.5256.54.6666.2694.804
SG&A -2.2818.354-2.53918.5630.72110.426-9.15317.5121.5976.805-5.14215.0682.3577.671-10.3288.4533.9079.2590.0588.1144.3516.8110.2537.2691.68210.287-11.53613.7841.68710.25-9.5469.34115.06610.81
Other Expenses 0.139-9.857-0.591-0.056-4.175-3.20713.5-11.12110.022-0.2920.758-0.0020.002-0.030.466-0.020.012-0.04-0.794-0.10.035-0.119-0.018-0.0520.016-0.02-3.9841.0650.4782.131.9551.1793.2471.443
Operating Expenses 30.11536.04632.56317.62619.72212.837.75812.46918.16912.29817.76315.01614.62212.9014.83714.79816.73113.39112.53914.92513.39910.52915.57910.61613.1067.7356.5715.10513.36611.58315.35210.21816.35911.677
Operating Income -77.379-24.114-152.26-39.11-34.192-10.57-55.233-35.11-14.169-4.665-26.055-13.0924.5591.509-2.2988.5925.87615.85527.04310.54918.23211.16316.71821.57326.80222.10420.76827.8322.79229.18313.27822.11633.90935.006
Operating Income Ratio -0.466-0.151-1.393-0.233-0.263-0.106-0.577-0.391-0.174-0.074-0.234-0.1670.0550.017-0.0340.1370.2710.1920.3250.1370.2410.1650.1840.2520.3410.2470.2390.2720.2560.30.140.2660.3130.304
Total Other Income Expenses Net 0.139-15.441-77.501-0.056-4.1750.061-0.254-0.05-18.172-6.4580.758-13.2760.912-8.9040.5781.8411.4620.7915.8331.3528.3080.8783.9911.08210.979-0.803-3.845-0.599-1.3840.8842.2471.2831.269-0.453
Income Before Tax -77.24-39.555-152.851-39.166-38.367-10.51-55.487-35.16-32.341-11.123-25.297-13.0934.561.48-1.8328.57125.88815.81526.24910.44918.26611.04316.70121.52126.81822.08416.78428.89623.2731.31313.55523.29534.94236.449
Income Before Tax Ratio -0.465-0.248-1.398-0.234-0.295-0.105-0.579-0.392-0.396-0.177-0.227-0.1670.0550.016-0.0270.1360.2710.1920.3150.1360.2410.1630.1840.2510.3410.2470.1930.2830.2610.3220.1430.280.3220.317
Income Tax Expense -21.099-8.045-16.8590.592-1.916-0.093-0.858-3.725-4.686-2.119-4.983-0.4780.369-0.815-1.5091.243.1612.6154.9290.4263.5440.2751.6923.1694.053.5232.543.9713.034.7970.8324.0295.4635.557
Net Income -55.736-31.343-135.738-39.415-36.52-10.417-54.628-31.435-27.654-9.004-20.072-12.5374.1632.402-0.0297.37422.66713.19621.6859.8414.67310.76815.00918.35222.76818.56114.24424.92420.2426.51612.72419.26629.47830.893
Net Income Ratio -0.336-0.197-1.242-0.235-0.281-0.104-0.57-0.35-0.339-0.144-0.18-0.160.050.026-00.1170.2370.160.260.1280.1940.1590.1660.2140.2890.2080.1640.2440.2270.2730.1340.2310.2720.268
EPS -0.36-0.2-0.88-0.26-0.24-0.068-0.36-0.21-0.19-0.061-0.12-0.10.0350.02-00.050.150.110.140.080.0940.0690.0940.120.140.120.0920.160.170.220.110.160.250.26
EPS Diluted -0.36-0.2-0.88-0.26-0.24-0.068-0.36-0.21-0.19-0.061-0.12-0.10.0350.02-00.050.150.110.140.080.0940.0690.0940.120.140.120.0920.160.170.220.110.160.250.26
EBITDA -30.362-11.759-82.873-49.423-8.04317.494-13.205-30.51-14.313-10.356-22.292-10.127.3053.817-2.1189.08829.79416.44529.60111.37619.5278.8528.91121.526.44423.15917.8528.68225.49330.76119.03721.99536.17837.256
EBITDA Ratio -0.183-0.074-0.758-0.295-0.0620.175-0.138-0.34-0.175-0.165-0.2-0.1290.0880.042-0.0320.1440.3120.1990.3550.1480.2580.130.3190.2510.3360.2590.2050.280.2860.3170.2010.2640.3340.324